A role for endothelin in neuropathic pain after chronic constriction injury of the sciatic nerve.
The purpose of this study was to explore the role of endothelin in neuropathic pain. Endothelins (ET) are a family (ET-1, ET-2, ET-3) of ubiquitously expressed peptides involved in control of vascular tone. Injected ET-1 causes intense pain via activation of ETA receptors, modulated by analgesic signals initiated by ETB receptor activation. Using a rat model of chronic constriction injury of the sciatic nerve, we found that pharmacologic ETA receptor antagonism acutely and significantly reduced thermal and mechanical hyperalgesic responses 5 days after injury. Furthermore, ET-1 and the ETA receptor are locally upregulated at the site of chronic constriction injury at both the message and the protein levels, suggesting that ET-1 may be involved in establishing pain after the injury. These data point to ET-1 as an important mediator of pain in general and suggest that ETA antagonism deserves study as a potential novel therapy for neuropathic pain.
Klass
Markus
M
Departments of Anesthesiology and Cell Biology, Emory University School of Medicine, Atlanta, Georgia.
Hord
Allen
A
Wilcox
Melissa
M
Denson
Don
D
Csete
Marie
M
D000818:Animals; D003251:Constriction, Pathologic; D065130:Endothelin A Receptor Antagonists; D019332:Endothelin-1 / Q000502:physiology*; D008297:Male; D010146:Pain / Q000188:drug therapy / Q000209:etiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D044022:Receptor, Endothelin A / Q000502:physiology; D020426:Sciatic Neuropathy / Q000150:complications*
D065130:Endothelin A Receptor Antagonists; D019332:Endothelin-1; D044022:Receptor, Endothelin A